Response to Letter to the Editor entitled “Methodological considerations in assessing the clinical impact of TP53 classifications in advanced NSCLC”

Lung Cancer 2026

View at publisher

Authors: Deborah Di-Xin Zhou, Chee Khoon Lee

DOI: 10.1016/j.lungcan.2026.109303

Cited by: 0

References: 3

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Cancer-related Molecular Pathways

References 3